SCHEMBL25864993

SCHEMBL25864993

COc1ccc(-c2ccc3oc(=O)n(C)c3c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
TSPO P30536 1/20 0.52
ASAH1 Q13510 2/20 0.48
MAPT P10636 3/20 0.48
TP53 P04637 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KMO O15229 1/20 0.48
HSD11B1 P28845 1/20 0.46
EGFR P00533 1/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.44
THRB P10828 1/20 0.44
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL783358 0.84 CYP11B2 (0.49) L3MBTL1CYP3A4GPR55
SCHEMBL22314900 0.83 MEN1 (0.45) MEN1KMT2ATSPOMAPTSMN1; SMN2
SCHEMBL20172639 0.83 GPR55 (0.46) MEN1KMT2ASMN1; SMN2HSD11B1ALDH1A1
SCHEMBL24981984 0.81 GPR55 (0.42) MEN1KMT2AL3MBTL1MAPTTP53
SCHEMBL18593724 0.79 KCNJ1 (0.45) MEN1KMT2AMAPTTP53SMN1; SMN2
SCHEMBL8296662 0.78 L3MBTL1 (0.60) MEN1KMT2AL3MBTL1TP53SMN1; SMN2
SCHEMBL25864996 0.77 TSPO (0.68) TSPOMAPTTP53SMN1; SMN2KMO
SCHEMBL782951 0.72 CYP19A1 (0.55) TSPOGPR55
SCHEMBL26527428 0.72 CTSC (0.46) L3MBTL1ASAH1ALDH1A1GPR55
SCHEMBL434086 0.72 MIF (0.54) MEN1KMT2AL3MBTL1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PREC MEDICINES INC (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B MEN1 1134/4885KMT2A 1112/4885L3MBTL1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.